Prognostic significance of lactate dehydrogenase in cabazitaxel chemotherapy for castration-resistant prostate cancer: a multi-institutional study-Reference-Cited by-同舟云学术

Prognostic significance of lactate dehydrogenase in cabazitaxel chemotherapy for castration-resistant prostate cancer: a multi-institutional study

Published:2020-03 Issue:3 Volume:31 Page:298-303
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Shiota Masaki,Nakamura Motonobu,Yokomizo Akira,Tomoda Toshihisa,Sakamoto Naotaka,Seki Narihito,Hasegawa Shuji,Yunoki Takakazu,Harano Masahiko,Kuroiwa Kentaro,Eto Masatoshi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference23 articles.

1. Taxane chemotherapy for hormone-naïve prostate cancer with its expanding role as breakthrough strategy.;Shiota;Front Oncol,2015

2. Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancer.;Shiota;Int J Urol,2016

3. Current treatment strategies for advanced prostate cancer.;Komura;Int J Urol,2018

4. Novel agents for castration-resistant prostate cancer: early experience and beyond.;Fujimoto;Int J Urol,2016

5. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial.;de Bono;Lancet,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival beyond cabazitaxel for metastatic castration‐resistant prostate cancer;International Journal of Urology;2024-03-05

2. Sequencing impact and prognostic factors in metastatic castration-resistant prostate cancer patients treated with cabazitaxel: A systematic review and meta-analysis;Urologic Oncology: Seminars and Original Investigations;2023-04

3. Efficacy of cabazitaxel in patients with metastatic castration‐resistant prostate cancer: A single‐center study in Japan;International Journal of Urology;2022-09-28

4. Impact of Gleason pattern 5 on prognosis for newly diagnosed metastatic hormone‐sensitive prostate cancer with Gleason score ≥8;International Journal of Urology;2022-01-18

5. Differential prognostic impact of complete blood count-related parameters by prior use of novel androgen receptor pathway inhibitors in docetaxel-treated castration-resistant prostate cancer patients;Anti-Cancer Drugs;2021-08-11